Related Experiment Video
Updated: Apr 20, 2026

08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
12.6K
Administration strategies for proteins and peptides
D Ibraheem1, A Elaissari1, H Fessi1
1University of Lyon, F-69622, Lyon, France, University Lyon-1, Villeurbanne, CNRS, UMR-5007, LAGEP- CPE, 43 bd 11 Novembre 1918, F-69622 Villeurbanne, France.
International Journal of Pharmaceutics
|December 3, 2014
Summary
Therapeutic proteins and peptides offer new treatment options for diseases like cancer. Researchers are exploring non-invasive delivery methods to improve drug efficacy and overcome challenges like poor bioavailability.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- Proteins and peptides are crucial for physiological processes and emerging as treatments for diseases like cancer and autoimmune disorders.
- Current parenteral administration routes for protein-based therapeutics present significant drawbacks including pain, cost, and toxicity.
- The development of effective protein and peptide drugs is hindered by challenges such as low bioavailability and in vivo instability.
Purpose of the Study:
- To review the potential of proteins and peptides as therapeutic agents.
- To discuss the limitations associated with current protein and peptide drug delivery methods.
- To highlight strategies for overcoming obstacles in protein and peptide drug delivery.
Main Methods:
- Review of existing literature on protein and peptide therapeutics.
- Analysis of non-invasive administration routes (nasal, pulmonary, oral, ocular, rectal).
- Examination of strategies to enhance drug efficacy, including permeability enhancement, enzyme inhibition, structural modification, and encapsulation.
Main Results:
- Proteins and peptides show promise for treating various serious diseases.
- Non-invasive delivery routes are being investigated as alternatives to parenteral administration.
- Strategies like encapsulation and structural modification can improve protein and peptide drug bioavailability and stability.
Conclusions:
- Proteins and peptides represent a significant area of therapeutic development.
- Overcoming delivery challenges is critical for the successful clinical application of protein and peptide drugs.
- Continued research into novel delivery systems and formulation strategies is essential to realize the full potential of these biomolecules.
Related Concept Videos
The Proteasome Structure
2.3K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
2.3K
Protein Folding
12.8K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
12.8K
The Proteasome
10.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K
Protein Digestion
120.3K
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
120.3K

